Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Innate Immunity Never “NODs” Off: NLRs Regulate the Host Anti‐Viral Immune Response
Mackenzie K. Woolls, Madeline Mott, Cassandra S. Poole, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 3
Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period
Danyi Ao, Xuemei He, Jian Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz
Bioorganic Chemistry (2023) Vol. 135, pp. 106390-106390
Open Access | Times Cited: 26
Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1339-1339
Open Access | Times Cited: 26
Cys44 of SARS-CoV-2 3CLpro affects its catalytic activity
Ilaria Iacobucci, Irene Cipollone, Flora Cozzolino, et al.
International Journal of Biological Macromolecules (2025), pp. 139590-139590
Closed Access | Times Cited: 1
Uncovering the naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the Chinese medicine sappanwood and deciphering their synergistic anti-Mpro effects
Qing Hu, Yiwen Zhang, Yani Zhang, et al.
Journal of Ethnopharmacology (2025), pp. 119397-119397
Closed Access | Times Cited: 1
Chili pepper: A delve into its nutritional values and roles in food-based therapy
Ayman Faris Faisal, Yasser Fakri Mustafa
Food Chemistry Advances (2025) Vol. 6, pp. 100928-100928
Closed Access | Times Cited: 1
In silico Study of Antiviral Activity of Polyphenol Compounds from Ocimum basilicum by Molecular Docking, ADMET, and Drug-Likeness Analysis
Dikdik Kurnia, Salsabila Aqila Putri, Sefren Geiner Tumilaar, et al.
Advances and Applications in Bioinformatics and Chemistry (2023) Vol. Volume 16, pp. 37-47
Open Access | Times Cited: 16
On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 16
Computational Discovery of Novel Imidazole Derivatives as Inhibitors of SARS-CoV-2 Main Protease: An Integrated Approach Combining Molecular Dynamics and Binding Affinity Analysis
Benjamin Ayodipupo Babalola, Abayomi Emmanuel Adegboyega
COVID (2024) Vol. 4, Iss. 6, pp. 672-695
Open Access | Times Cited: 7
Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
Rishikesh Lotke, Moritz Petersen, Daniel Sauter
Viruses (2024) Vol. 16, Iss. 3, pp. 332-332
Open Access | Times Cited: 6
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Phytomedicine (2023) Vol. 114, pp. 154796-154796
Open Access | Times Cited: 15
Future of the current anticoronaviral agents: A viewpoint on the validation for the next COVIDs and pandemics
Amgad M. Rabie
Biocell (2023) Vol. 47, Iss. 10, pp. 2133-2139
Open Access | Times Cited: 15
Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study
Cecep Suhandi, Siti Sarah Alfathonah, Aliya Nur Hasanah
Molecules (2023) Vol. 28, Iss. 13, pp. 5187-5187
Open Access | Times Cited: 13
Recent Advances on SARS-CoV-2 Mpro Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
(2023)
Open Access | Times Cited: 13
Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors
Davood Gheidari, Morteza Mehrdad, Mohammad Bayat
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299301-e0299301
Open Access | Times Cited: 4
Influence of EGCG oxidation on inhibitory activity against the SARS-CoV-2 main protease
Yufeng He, Meng Hao, Mingchuan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133451-133451
Closed Access | Times Cited: 4
Toward the Design of Allosteric Effectors: Gaining Comprehensive Control of Drug Properties and Actions
Wei-Ven Tee, Sylvester Jian Ming Lim, Igor N. Berezovsky
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 4
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro
Jiayi Ren, Zhengfu Zhang, Yi Xia, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 351-351
Open Access
Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme
Ann Varghese, Jie Liu, Bailang Liu, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 491-491
Open Access
Distal protein-protein interactions contribute to nirmatrelvir resistance
Eric M. Lewandowski, Xiujun Zhang, Haozhou Tan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tea Catechins in Green Tea Inhibit the Activity of SARS-CoV-2 Main Protease via Covalent Adduction
Yoji Kato, Sakiko Suzuki, Akari Higashiyama, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Page 1 - Next Page

Scroll to top